Biotech China 2014

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Microfluidics for IVD analysis: triumphs and hurdles of centrifugal platforms, Part 2: Centrifugal microfluidics Centrifugal microfluidics. IVD Technology, 16 (1) :
2. 2010 Toward Automatic Label-Free Whispering Gallery Modes Biodetection with a Quantum Dot-Coated Microsphere Population NANOSCALE RESEARCH LETTERS 5(3): 524-532.
3. 2010 Efficacy of Gel formulations containing free and liposomal foscarnet in a murine model of cutaneous HSV-1 Infection Journal of Liposome Research. 9:181-198.
4. 2010 A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women Contraception 81:79-85.
5. 2010 Validation of a centrifugal microfluidic sample lysis and homogenization platform for nucleic acid extraction with clinical samples Lab Chip. 2010 Feb 7;10(3):363-71. Epub 2009 Nov 23.
6. 2009 Internal control for nucleic acid testing based on the use of purified Bacillus atrophaeus subsp. globigii spores J Clin Microbiol 47(3): 751-7.
7. 2009 Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces Int J Syst Evol Microbiol 59(Pt 3): 498-503.
8. 2009 Analytical limits of three beta-glucosidase-based commercial culture methods used in environmental microbiology, to detect enterococci Water Sci Technol 60(4): 943-55.
9. 2009 Onsite Microbiological Quality Monitoring of Raw Source Water in Cree Community of Mistissini Water Quality Research Journal of Canada 44(4):345-354
10. 2009 Microfluidics for IVD analysis: triumphs and hurdles of centrifugal platforms Part 1: Molecular fundamentals. IVD Technology 15(9):26-33.
11. 2009 Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia J Virol 83(3): 1341-9.
12. 2009 Analytical comparison of nine PCR primer sets designed to detect the presence of Escherichia coli/Shigella in water samples Water Res.43 :3019-3028
13. 2009 A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon. Contraception 80(5): 484-92.
14. 2009 Commentary: HIV/AIDS therapy and prevention: The two solitudes. Can. J. Infect. Dis. Med. Microbiol. 20(2):e15-e18.
15. 2008 New Molecular Technologies against infectious diseases during space flight Acta Astronautica 63: 769-775
16. 2008 Analytical limits of four ß-galactosidase-based commercial culture methods used to detect Escherichia coli and total coliforms Journal of Microbiological Methods 75: 506-514.
17. 2008 Divergence among genes encoding the elongation factor Tu of Yersinia Species. J Bacteriol 190(22): 7548-7558
18. 2008 Plastic polymers for efficient DNA microarray hybridization: application to microbiological diagnostics Journal of Clinical Microbiology 46: 3752-3758.
19. 2008 Ruminococcus gauvreauii sp. nov., a glycopeptide-resistant species isolated from a human faecal specimen Int J Syst Evol Microbiol 58(Pt 6): 1393-7.
20. 2008 Assessment of microbiological quality of drinking water from household tanks in Bermuda Can J Microbiol 54(6): 495-500
21. 2008 Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study Contraception 77(6): 447-55
22. 2008 Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria ACS Nano 2(9): 1777-88.
23. 2008 Superparamagnetic nanoparticle-polystyrene bead conjugates as pathogen capture mimics: a parametric study of factors affecting capture efficiency and specificity Langmuir 24(7): 3493-502.
24. 2008 Human bocavirus infections in hospitalized children and adults Emerg Infect Dis 14(2): 217-21.
25. 2008 Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models Piret, J., G. Laforest, M. Bussieres and M. G. Bergeron
26. 2008 Nucleotide sequence and phylogenetic analysis of a new potexvirus: Malva mosaic virus Infect Genet Evol 8(1): 83-93.
27. 2008 Pulmonary infections in the immunocompromised host Publisher: Simpson D., Churchill Livingston, Elsevier, Philadelphia, PA, USA
28. 2008 Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models J Appl Toxicol 28(2): 164-74
29. 2008 Subcutaneous injection of Mycobacterium ulcerans causes necrosis, chronic inflammatory response and fibrosis in skeletal muscle Microbes Infect 10(12-13): 1236-43
30. 2007 Differential contribution of bacterial fMLP and host-derived CXC chemokines on neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia Infect Immun
31. 2007 Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners Contraception 76:117-125.
32. 2007 Specific magnetic bead based capture of genomic DNA from clinical samples: application to the detection of group B streptococci in vaginal/anal swabs Clin Chem 53:1570-1576.
33. 2007 Surface modification of thermoplastics-towards the plastic biochip for high throughput screening devices Lab Chip 7(7): 856-62.
34. 2007 A low-cost, disposable card for rapid polymerase chain reaction Colloids Surf B Biointerfaces 58(1): 52-60
35. 2007 Complete nucleotide sequence of Nootka lupine vein-clearing virus Virus Genes 35(3): 807-14.
36. 2007 Rapid exonuclease digestion of pcr-amplified targets for improved microarray hybridization. Clin Chem 53(11): 2020-3
37. 2007 vanD and vanG-like gene clusters in a Ruminococcus species isolated from human bowel flora Antimicrob Agents Chemother 51(11): 4111-7
38. 2007 Poirier and M. Ouellette. 2007. Comparative Proteomics Analyses Reveal a Potential Biomarker for the Detection of Vancomycin-Intermediate Staphylococcus aureus Strains J Proteome Res
39. 2006 Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons Journal of Infectious diseases 193:54-8
40. 2006 Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine. Expert Rev Mol Diagn 6:433-450
41. 2006 Rapid and automated sample preparation for nucleic acid extraction on a microfluidic CD (compact disk). Proceedings of SPIEMicrofluidics 6112, 611204.
42. 2006 Cytokine and chemokine network in the infected lung in Respiratory Infections Edward Arnold Health Sciences Ltd (Publishers).
43. 2006 Human parainfluenza type 4 infections, Canada Emerg Infect Dis 12(11): 1755-8
44. 2006 Real-Time PCR: Analite-specific reagents vs FDA-approved kit Microbe 1(5):209-210 (Letter).
45. 2006 Dynamic automated DNA hybridization on a CD (compact disc) fluidic platform Sensors and Actuators B 114: 173-181
46. 2005 Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania sp Molecular and Biochemical Parasitology. 140:205-220.
47. 2005 Direct molecular detection of nucleic acids by fluorescence signal amplification J Am Chem Soc 127(36): 12673-6
48. 2005 Infections by human coronavirus-NL in hospitalized children Pediatr Infect Dis J 24(12): 1045-8.
49. 2005 Microfluidic device for rapid (15 min) automated microarray hybridization. Clinical Chemistry. 51.1836-1844.
50. 2005 Phylogeny of the Enterobacteriaceae based on genes encoding elongation factor Tu and F-ATPase ß-subunit. International Journal of Systematic and Evolutionary Microbiology. 55.2013-2025.
51. 2005 A proteomic analysis of penicillin reisitance in streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter. Molecular Microbiology. 58.1430-1440.
52. 2005 High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora J Antimicrobial Chemotherapy. 49.11.4784-4786.
53. 2005 Detection of target DNA using fluorescent cationic polymer and peptide nucleic acid probes on solid support BMC Biotechnology. 5:10
54. 2005 Correlation between microarray DNA hybridisation efficiency and the position of short capture probe on the target nucleic acid. Biotechniques 89(1):89-96.
55. 2005 Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia. J. Antimicrobial Chemotherapy. 55:721-726.
56. 2005 Lymphoid tissue targeting of anti-HIV drugs using liposomes. Methods in enzymology. Editors-in-chief, John N. Abelson and Melvin I. Simon. Edited by Nejat Düzgüne. Vol. 391. Section II. Liposomal antibacterial, antifungal and antiviral agents. Chapter 19. 330-351
57. 2005 Characterization of Tn5382-like transposon containing the vanB2 gene cluster in a Clostridium strain isolated from human faeces J Antimicrobial Chemotherapy. 55-466-474.
58. 2005 Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program Clin. Infect. Dis. 40:977-981
59. 2005 DNA-sensors using a water-soluble, cationic poly(thiophene) derivative Volume methods in enzymology on liposomes. Editeur, JN. Abelson et MI. Simon
60. 2004 Fluorescent polymeric transducer for the rapid, simple, and specific detection of nucleic acids at the Zeptomole level J. Am. Chem. Soc. 126:4240 - 4244.
61. 2004 Health and economics benefits of an accelerated program of research to combat global infectious diseases Canadian Medical Association Journal. 171:1203-1208, 2004.
62. 2004 Clostridium difficile. Marcel Dekker, Inc. NY. 270-274.
63. 2004 New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women. Reproductive Medicine Review. 11:1 25-41.
64. 2004 Use of tuf sequences for genus-specific PCR detection and phylogenetic analysis of 28 streptococcal species using tuf sequences Journal of clinical Microbiology. 42:3686-3695.
65. 2004 Laboratory detection of group B streptococcus for prevention of perinatal diseases. Eur J Clin Microbiol Infect Dis. 23:665-671.
66. 2004 The Invisible Condom: A unique mode of action with a low toxicity profile. International Proceedings. XV International AIDS Conference. Bangkok (Thailand), 11-16 juillet.
67. 2004 Elongation factor Tu and the F-ATPase beta-subunit as phylogenetic tools for species of the family Enterobacteriaceae International Journal of Systematic and Evolutionary Microbiology.
68. 2004 New real-time PCR assay for rapid ( 1 hour) detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci Journal of Clinical Microbiology. 42 : 1875-1884.
69. 2004 In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002 Antimicrobial Agents Chemotherapy. 48:3305-3311.
70. 2003 Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device Biology of reproduction. 69:687-394
71. 2003 Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays Nucleic Acids Research. 31:5886-5896
72. 2003 Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses Journal of Clinical Microbiology. 42:45-51.
73. 2003 Real-time PCR assay for detection of fluoroquikolone resistance associated with grlA mutations in Staphylococcus aureus Journal of Clinical Microbiology. 41:3246-3251
74. 2003 Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase. Clinical Immunology. 108: 111-118
75. 2003 Human metapneumovirus infections in hospitalized children Emerging Infectious Diseases. 9:634-640.
76. 2003 Rapid detection of Clostridium difficile in feces by real-time PCR Journal of Clinical Microbiology. 41:730-734.
77. 2002 Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. Biochimica & Biophysica Acta. 1558-198-210.
78. 2002 Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J Immunology. 168:1813-1822
79. 2002 Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin. Antimicrobial Agents Chemotherapy. 45:2623-2627.
80. 2002 Prevention des infections opportunistes chez les adultes infectes par le VIH November
81. 2002 Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses. Current Drug Targets. 3:17-30.
82. 2002 Rapid detection of shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the Smart Cycler. Journal of Clinical Microbiology. 40:1436-1440.
83. 2002 Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice Infection and Immunity. 70:4226-4238.
84. 2002 Comparative study of the mechanisms of Herpes Simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine Antimicrobial Agents Chemotherapy. 46:2933-2942.
85. 2002 Toward rapid real-time molecular diagnostic to guide smart use of antimicrobials. Current Opinion in Microbiology. 5:478-482.
86. 2002 Rapid molecular theranostics in infectious diseases Reviews. Therapeutic focus. Drug Discovery Today. 21:1092-1101.
87. 2002 Colorimetric and fluorometric detection of nucleic acids using cationic polythiophene derivatives Angew. Chem. Int. Ed. 41:1548-1551.
88. 2001 Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model for pneumococcal pneumonia: effects of lung inflammation and timing of treatment Journal of Infectious Diseases. 183:70-77.
89. 2001 Kinetic study of the inflammatory response in streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004. Antimicrobial Agents Chemotherapy. 45:252-262
90. 2001 Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment Antimicrobial Agents Chemotherapy. 45:2229-2237.
91. 2001 Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sufate, on the establishment and reactivation of latent herpes simplex virus type-1. Antimicrobial Agents Chemotherapy. 45:1030-1036.
92. 2001 Rapid detection of group B streptococci using the LightCycler. Verlag GmbH and Co. KG.
93. 2001 Rapid Polymerase chain reaction detection of bacteria and their antibiotic resistance genes Current Infectious Disease Reports. Current Science, Inc. 3-201-202.
94. 2001 Development of a rapid PCR assay for identification of staphylococci at genus and species levels Journal of Clinical Microbiology. 39:2541-2547.
95. 2001 New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women Expert Rev. Mol. Med. November 2001:1-13.
96. 2001 Molecular methods for rapid detection of group B Streptococci. Expert Rev Mol. Diagn. 1:175-181.
97. 2001 Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia Journal of Infectious Diseases. 184:292-300.
98. 2001 Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and Herpes simplex virus type 2 Sex. Transm. Dis. 28:484-491.
99. 2001 Pulmonary and systemic host response to Streptotoccus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice Infection and Immunity 69:5294-5304.
100. 2001 Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/ macrophage recruitment J Immunol. 166:7353-7361.
101. 2001 Thermoreversible gel formulations containing sodium lauryl sulfate and n-lauroylsarcosine as potential topical microbicides against STDs Antimicroial Agents Chemotherapy. 45:1671-1681.
102. 2000 Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B. AIDS 14:2457-2465.
103. 2000 Multiplex PCR assays for the detection of clinically relevant antibiotic resistance genes in staphylococci isolated from patients infected after cardiac surgery J Antimicrobial Chemotherapy. 46:527-533.
104. 2000 Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneunococcal pneumonia Journal of Infectious Diseases. 182:1255-1259
105. 2000 Comparative efficy of teicoplanin and cefazolin for cardiac surgery prophylaxis in 3027 patients J Thoracic and Cardiovascular Surgery. 120:1120-1130.
106. 2000 Evidence for horizontal gene transfer in the evolution of the elongation factor Tu in enterococci J Bacteriology. 182:6913-6920
107. 2000 Rapid detection of Group B Streptococci in pregnant women at delivery New England Journal of Medicine 343:175-179
108. 2000 A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia. Journal of Infectious Diseases. 182:970-973.
109. 2000 Sterically stabilized liposomes bering anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1. Biochimica & Biophysica Acta. 1468:161-174
110. 2000 Development of a rapid PCR assay specific for Staphylococcus saprophyticus and application to direct detection from urine samples J Clinical Microbiology. 38:3280-3284.
111. 2000 Sodium lauryl increases the efficacy of topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice Antimicrobial Agents Chemotherapy. 44:2263-2270.
112. 2000 Genetic tools for the simultaneous identification of bacterial species and their antibiotic resistance genes: impact on clinical practice Int J Antimicrob Agents. 16:1-3.
113. 2000 Development of conventional and real-time PCR assays for the rapid detection of Group B streptococci Clinical Chemistry. 46:324-331.
114. 2000 Interaction between virion-bound host ICAM-1 and the high affinity state of LFA-1 on target cells renders R5 and X4 isolates of HIV-1 more refractory to neutralizaiton. Virology. 268:493-503.
115. 2000 Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis Antimicrobial Agents Chemotherapy. 44: 231-238
116. 2000 In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against Herpes simplex and human immunodeficiency viruses. Journal of Clinical Microbiology. 38:110-119.
117. 2000 Efficacy of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection Antimicrobial Agents Chemotherapy. 44:30-38.
118. 2000 Novel genus-specific PCR-based assays for rapid identification of neisseria species and neisseria meningitidis Eur J Clin Microbiol Infect Dis.19:443-451
119. 1999 Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis Journal of Infectious Diseases. 179:1162-1172.
120. 1999 Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration Antimicrobial Agents Chemotherapy. 43:1020-1026
121. 1999 Reducing chorioretinal viral counts with intravitreal foscarnet injections in a rabbitt model of Herpes simplex virus type-1 retinitis Ocular Pharmacology and Therapeutics. 15:465-477.
122. 1999 Protective effect of gel against the toxicity of nonoxynol-9 Sex Transm. Dis. 26:177-183.
123. 1999 Veilleux. 1999. Traduction et validation quebecoise du Miller Behavioral Style Scale auprs de la population seropositive au VIH Science et comportement. 27:17-35.
124. 1999 Pharmacologic basis for the treatment of UTI. Current Infectious Diseases Report. Urinary tract infections and female pelvis Edited by JD. Sobel. and GL. Mandell, Editor. 1:371-378.
125. 1999 Pourquoi developper des tests rapides (<1 h) d'identification bactérienne a base d'ADN AMMIQale, 7:33-35. March 1999
126. 1999 The infinitely small: A mission, a passion, a vision for the 21st century. Can J Infect Dis. Special Supplement. May 1999; 10 (supp. C). 2C-3C.
127. 1999 In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible and penicillin-resistant pneumococcal pneumonia. Antimicrobial Agents Chemotherapy. 44:1010-1018.
128. 1999 Development of a PCR assay for rapid detection of enterococci. Journal Clinical Microbiologyl. 37:3497-3503.
129. 1999 Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab'fragments. Biochimica & Biophysa Acta. 1421:284-294.
130. 1999 Canadian bacterial surveillance network. decreased susceptibility of S. pneumoniae from across Canada to fluoroquinolones New England Journal of Medicine. 341:233-239.
131. 1999 Influence of defodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice. Antimicrobial Agents Chemotherapy. 43:2291-2294.
132. 1999 Immunomodulation of pneumococcal pulmonary infection with NG-monomethyl-L-Arginine Antimicrobial Agents Chemotherapy. 43:2283-2290.
133. 1999 Roles of galectin-3 in streptococcal pneumonia XV International Symposium on Glycoconjugates, Japan, Tokyo. Glycoconjugate J. 16;S65.
134. 1999 Why does the pneumococcus kill? Special supplement. Can J Infect Dis. Special supplement. May 1999;10(suppl. C). 49C-60C.
135. 1999 Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma Journal of Infectious Diseases. 179: 1101-1107.
136. 1999 Rapid diagnosis of bacterial infections using technologies based on nucleic acid detection. Special supplement. Canadian J Infectious Diseases. Special supplement May 1999, 10;(suppl. C). 16C-24C).
137. 1999 Topical microbicides for the prevention of STDs/HIV. Can J Infect Dis. Special supplement. May 99, 10;(suppl. C). 41C-48C.
138. 1998 Intracellular and serum stability of liposomal 2,3-dideoxycytidine. Effect of lipid composition Cell Mol Biol. 44(2):277-284.
139. 1998 Clindamycin with primaquine versus trimethoprim-sulphamethoxazole for mild and moderately severe pneumocystis carinii pneumonia in AIDS patients. A multicenter, double-blind randomized trial (CTN 004). Clinical Infectious Diseases. 27:524-530.
140. 1998 Evaluating anxiety and depression in HIV-infected patients J Personality Assessment. 7:349-367.
141. 1998 Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice Infection and Immunity. 66:912-922
142. 1998 Scientists Inc. Illusion or disillusion? Clin Invest Med. 21(1):39-44.
143. 1998 Identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory Journal Clinical Microbiology. 36:2169-2172.
144. 1998 Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice Journal of Infectious Diseases. 178: (5) 1472-1482.
145. 1998 Liposomes as drug delivery system: A strategic approach for the treatment of HIV infection J Drug Targeting. 6:1-15.
146. 1998 Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats Antimicrobial Agents Chemotherapy. 43:520-524.
147. 1998 Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice Antimicrobial Agents Chemotherapy. 42:3309-3312
148. 1998 Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice Antimicrobial Agents Chemotherapy. 42:2527-2533.
149. 1998 Emergence and prevalance of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. AIDS. 12:125-129
150. 1998 Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects Journal of Infectious Diseases.. 177:355-360.
151. 1998 Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects J Clin Microbiol. 1998, 36(9): 2509-2513.
152. 1998 Relationship between intrarenal distribution and efficacy of fleroxacin in the treatment of Escherichia coli pyelonephritis in rats. J. Infect. Chemother. 4:179-185.
153. 1998 Species-specific and ubiquitous DNA-based assays for rapid identification of Staphylocccus aureus Journal Clinical Microbiology. 36:618:623.
154. 1998 Papadopoulou. 1998. Protection against leishmania major challenge infection in mice vaccinated with live recombinant parasites expressing a cytotoxic genes. Journal of Infectious Diseases. 177:188-195.
155. 1998 Le diagnostic des maladies infectieuses en une heure: une révolution nécessaire. Les Sélections de médecine/sciences. 13:998-1001
156. 1998 Principes pharmacologiques du taitement de la pyélonéphrite: distribution, efficacité et toxicité rénale des antibiotiques. Les Sélections de médecine/sciences 8:22-31.
157. 1998 Scientists Inc. Illusion or disillusion? Clin. Invest. Med., 21(1):39-44.
158. 1998 Guide de la therapie antiretrovirale chez les adultes infectes par le virus d'immunodeficience humaine (VIH). Info-Medicament 14: April 1998. 1-20.
159. 1998 Evaluating anxiety and depression in HIV-infected patients J Personality Assessment. 7:349-367
160. 1998 Aminosides et les polypeptides. Pharmacologie, M. Schorderet et al. Edition Frison-Roche- Slatkine, Paris 3rd edition.
161. 1998 Prototype forms gel barrier Network. Family Health International. 18, 2:19. 1998.
162. 1998 Guide d'utilisation du test de la charge viral chez les adultes infectes par le virus d'immunodeficience humaine (VIH). Info-Medicament 13: April 1998. 1-8.
163. 1997 Atlas of infectious diseases pyelonephritis. Vol. IX. Urinary tract infections and infections of the female pelvis Editor : JD. Sobel.
164. 1997 Attenuation of gentamicin-induced experimental nephrotoxicity by fleroxacin Antimicrobial Agents Chemotherapy. 41:1237-1245.
165. 1997 Time-restricted feeding schedules modify temporal variation of gentamicin experimental nephrotoxicity Antimicrobial Agents Chemotherapy. 41:1468-1474.
166. 1997 Combination of fluoxetine and cognitive therapy for the treatment of major depression among people with HIV infection: a time series, analysis investigation Cognitive Therapy and Res. 22:21-46.
167. 1997 Quantitation of cytomegalovirus (CMV) DNA in leukocytes of HIV-infected subjects with and without CMV disease using PCR and the SHARP signal detection system Journal of Clinical Microbiology.. 35:525-526.
168. 1997 Drug sensitivity of human immunodeficiency virus type-1 isolates after ribavirin therapy Journal of Iinfectious Diseases. 175:176-178.
169. 1997 The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and man. Journal Antimicrobial Chemotherapy. 39 (Suppl A): 129-138
170. 1997 Differential tissue distribution, efficacy, and in vivo bacterial morphological changes observed following aztreonam and ceftazidime Antimicrobial Agents Chemotherapy. 41:401-409.
171. 1997 A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments. AIDS. 11:867-873.
172. 1997 Nitric oxide production by kidney proximal tubular cells in response to lipopolysaccharide and cytokines is associated with cellular damage Nitric oxide production by kidney proximal tubular cells in response to lipopolysaccharide and cytokines is associated with cellular damage
173. 1997 Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in MAIDS model Toxicol Appl Pharmacol. 143:140-151.
174. 1996 Effects of fasting on the temporal variations in the nephrotoxicity of gentamicin in rats Antimicrobial Agents Chemotherapy. 40:670-676.
175. 1996 Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-Dideoxyinosine Antimicrobial Agents Chemotherapy. 40:225-229.
176. 1996 Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration. Antimicrobial Agents Chemotherapy. 40:203-211.
177. 1996 Nephrotoxicity of amphotericin B in rats: effects of the time of administration. Life Sciences. 58:869-876.
178. 1996 Antiviral efficacy and toxicity of ribavirin in MAIDS model. J Acq Immun Defic Syndr. 12:451-461.
179. 1996 Effect of daptomycin on the barotropic behavior of dioleoylphosphatidylglycerol; an infrared spectroscopic investigation Chem Phys Lipids. 83:131-140.
180. 1996 Species-specific and ubiquitous DNA-based assays for rapid identification of Staphylococcus epidermidis. Journal of Clinical Microbiology. 34:2888-2893.
181. 1996 Ribavirin potentiates the efficacy and toxicity of ddI in murine acquired immunodeficiency syndrome model J. Pharmacol Exp Ther. 279:1009-1017.
182. 1996 Que connaet-t-on sur la prevalence, l'Evaluation et le traitement de la depression dans le contexte du VIH? Revue quebecoise de psychologie, 17:103-131.
183. 1996 In vivo toxicity of foscarnet and zidovudine each alone or in combination Toxicol Applied Pharmacol . 139:324-332.
184. 1996 Influence of a circadian-stage-dependent dosing schedule on the pharmacokinetics of isepamicin in humans J Infect Chemother. 2:106-109.
185. 1996 Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 Cells/mm3 Annals of Internal Medicine. 123:8;561-571.
186. 1996 Day-night treatment difference of tobramycin serum and intrarenal drug distribution and nephrotoxicity in rats: Effects of fasting Chronobiol Int. 13:113-121.
187. 1996 Temporal variation in nephrotoxicity of low doses of isepamicin in rats. Antimicrobial Agents Chemotherapy. 40:802-806.
188. 1995 Targeting HIV with liposome-encapsulated antivirals. Intern J of Medical Microbiology, Virology, Parasitology and Infectious Diseases. 282:225-231
189. 1995 Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet. Antimicrobial Agents Chemotherapy. 39:1973-1978
190. 1995 Circadian variations in the intrarenal accumulation kinetics of tobramycin in conscious rats Chronobiol Int. 12:188-194.
191. 1995 Histoire naturelle du SIDA dans VIH/SIDA: Une approche multidisciplinaire. Reflexions et strategies pour les professionnels de la Sante Editor Gaetan Morin Ltee. L'avenir de l'epidemie et des traitements. Chapter 50, 567-582.
192. 1995 La syphilis chez le patient infecte par le VIH dans Le Sida Edited by the Association des medecins de langue française. 13:239-248.
193. 1995 Treatment of pyelonephritis in adults Antimicrobial Therapy I. 79:619-648.
194. 1995 Est-ce encore possible de reduire l'incidence de la nephrotoxicite des aminosides? Patho. Biology. 43:779-787.
195. 1995 Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats Life Sciences. 56:1877-1887.
196. 1995 Molecular basis of the inhibition of gentamicin nephrotoxicity by daptomycin; an infrared spectroscopic investigation Biochimica et Biophysica Acta. 1237:86-94.
197. 1995 Lymphoid tissues targeting of liposome-encapsulated 2'-3 dideoxyinosine AIDS. 9:701-707.
198. 1995 Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics AIDS . 9:833-841.
199. 1995 American J. Medicine. 99:1S-3S. Proceedings of the plenary sessions. 19th International Congress of Chemotheapy. Introduction: a turning point
200. 1995 Diagnosing bacterial infectious diseases in one hour: an essential upcoming revolution Editorial. Infection 23:69-72.
201. 1994 L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis. Antimicrobial Agents Chemotherapy. 38:1555-1560
202. 1994 Determination of antimicrobial susceptibilities of canadian isolates of Haemophilus influenzae and characterization of their -lactamases Antimicrobial Agents Chemotherapy. 38:1678-1680.
203. 1994 Bactericidal Activity of Cefpirome (HR 810) against 513 Gram-negative bacteria isolated from blood of septicemic patients Infection. 22 4:/71.299-304.
204. 1994 Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2'-3" dideoxyinoside (ddi). AIDS. 8:1545-1553.
205. 1994 Chrononephrotoxicity of low doses of tobramycin in rats Life Sciences. 55:169-177
206. 1994 Comparison of cellular accumulation, tissue distribution, and anti-human immunodeficiency virus activity of free and liposomal 2',3'-dideoxycytidine AIDS Research and Human Retroviruses.10:1463-1470.
207. 1994 Uptake and binding of liposomal 2'-3' dideoxycytidine by RAW 264.7 cells: a three-step process J Acquir. Immun. Defic. Syndrome. 8:227-235.
208. 1994 Molecular typing of Haemophilus influenzae using a DNA probe and multiplex PCR Mol. Cell. Probes 8:23-37.
209. 1994 Mechanisms of the inhibition of aminoglycosides nephrotoxicity by daptomycin: A biochemical and infrared spectroscopic investigation. Recent Advances in Chemotherapy. ASM 207-209.
210. 1994 Attenuation of daptomycin and gentamicin induced experimental nephrotoxicity. Antimicrobial Agents Chemotherapy. 38:1027-1035.
211. 1994 Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin Experimental and Molecular Pathology 60:197-213
212. 1994 Ceftriaxone protects against tobramycin nephrotoxicity. Antimicrobial Agents Chemotherapy. 38:750-756.
213. 1994 Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin Antimicrobial Agents Chemotherapy. 38:742-749.
214. 1994 Subcellular distribution of daptomycin given alone or with tobramycin in renal proximal tubular cells. Antimicrobial Agents Chemotherapy. 38:189-194.
215. 1994 Temporal changes of pharmacokinetics nephrotoxicity, and subcellular distribution of tobramycin in rats Antimicrobial Agents Chemotherapy. 38:54-60
216. 1994 Nephrotoxicity of low doses of tobramycin in rats: Effect of the time of administration Life Sciences. 55:169-177.
217. 1994 Penemes, Carbapenemes et Monobactames dans Medicaments anti-infectieux. Editeur Claude Carbon. Flammarion. Medecine-Sciences. p. 91-101
218. 1994 Current trends in anti-microbial use: A practical guide Module 3. Economic impact of sequential antibiotic therapy. pp. 12-19.
219. 1994 Les raisons fondamentales du traitement antibiotique sequenciel. Dans tendances Actuelles dans l'administration des antimicrobiens: Un guide pratique. 1-12, MEDED.
220. 1993 Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy. Antimicrobial Agents Chemotherapy. 37:2727-2732.
221. 1993 Characterization of multiresistant strains of Neisseria gonorrhoeae isolated in Nicaragua Sex Transm Dis. 20:314-320.
222. 1993 Pharmacodynamics of antibiotics in fibrin clots J. Antimicrobial. Chemotherapy. 31: 113-136.
223. 1993 Epidemiological typing of Moraxella catarrhalis using DNA probes. Journal of Clinical Microbiology. 31(3):736-739.
224. 1993 Les maladies transmissibles sexuellement. L'approche globale des MTS et l'entrevue Press of the University of Montreal. Collection Omnipraticien. P. 49-60.
225. 1993 Microbiological spectrum and pharmacokinetic profile of clarithromycin. In Infections in Medicine Antimicrobial therapy. 12-20.
226. 1993 Dans l'approche globale des MTS et l'entrevue. Les maladies transmissibles sexuellement. Book chapter: Presses de l'Universite de Montreal. Collection Omnipraticien. 49-60.
227. 1992 Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells determined by immunogold labeling. Antimicrobial Agents Chemotherapy. 36:2204-2210.
228. 1992 What pre-clinical data are needed to justify once daily therapy? Journal of Clinical Pharmacology. 32:698-705
229. 1992 Canadian guidelines for the prevention, diagnosis, management and treatment of sexually transmitted diseases in neonates, children, adolescents and adults Canada Communicable Disease Report. April.
230. 1992 In vitro activity of clarithromycin and its 14-Hydroxy-Metabolite against 203 strains of Haemophilus influenzae Infection Schriftleitung. 20: 3:54/164-167.
231. 1992 Pharmacodynamic interaction between RP 59500 and Gram positive bacteria infecting fibrin clots Antimicrob Agents Chemother. 36:2211-2215
232. 1992 Aminosides et polypeptides. In : Pharmacologie. Des concepts fondamentaux aux applications therapeutiques. Michel Schorderet et coll. Edition Frison-Roche-Slatkine, Paris 2nd edition.
233. 1992 Inc : Introduction. Actes condenses du colloque: Travailler sur le SIDA au Quebec. Montreal. Oct. 8th
234. 1992 Antibiotic susceptibility profiles of 941 Gram-negative bacteria isolated from septicemic patients throughout Canada Clinical Infectious diseases. 15:615-28.
235. 1992 In : Clinical Management. AIDS 91 Summary AIDS 91 Summary. A practical synopsis of the VII international conference. 7 :214-252.
236. 1992 Fonds de la recherche en sante du Quebec. Rapport consultatif des 11 themes prioritaires du gouvernement quebecois en matiere de sante Redaction, Objectif 17: D'ici l'an 2000
237. 1992 Age-dependent gentamicin experimental nephrotoxicity J Pharmacol Exp Ther. 260:444-449.
238. 1992 strains of Haemophilus influenzae isolate in Canada Antimicrobial Agents Chemotherapy. 36:1504-1513.
239. 1992 Epidermal growth factor (EGF) accelerates renal tissue repair in a rat model of gentamicin nephrotoxicity. Am J Physiol. 263:F806-811.
240. 1992 Proceedings of the First International Congress on Biological Response modifiers. The therapy of the future. Introduction Can J Infect Dis. 3. Supp. B. 1-2. 1992.
241. 1991 In : Reconnaitre, comprendre et traiter les infections Infections intra-abdominales. 3rd edition. 18 :291-314.
242. 1991 Randomized, double-blind, placebo-controlled, clinic-initiated, canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes Journal Infectious Diseases. 164:665-72.
243. 1991 Development of a species-specific DNA probe for Moraxella (Branhamella) catarrhalis. Molecular and Cellular Probes Molecular Cellular probes. 5:37-48.
244. 1991 Endotoxin and tobramycin exhibit potentiated toxicity on rabbit proximal tubular cells in culture. Antimicrobil. Agents Chemotherapy. 35:351-357.
245. 1991 Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold-labeling Antimicrobial Agents Chemotherapy. 35:2173-2179.
246. 1991 In : Medical Masterclasses. Factors affecting tissue penetration of antibiotics. Vol. 1 (Bergan, T. Ed.) :15-26.
247. 1991 Modulation of aminoglycoside nephrotoxicity Clin. Invest. Med. 14(4): A73
248. 1990 Effects of daptomycin and vancomycin on tobramycin nephrotoxocity in rats. Antimicrobial Agents Chemotherapy. 34:139-147.
249. 1990 Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria Can Med Assoc. J. 142-1209-1212.
250. 1990 In : Clinical Management. AIDS Summary. A practical synopsis of the VI international conference. Editor Philadelphia Sciences Group. 168-228
251. 1990 Effect of E. coli pyelonephritis on the intrarenal accumulation kinetics of gentamicin and netilmicin in rats Clin Invest Med. 13:145-151
252. 1990 In : International trends in thoracic surgery. Empyema, medical management. The changing bacterial spectrum and antibiotic choices. Thoracic surgery: surgical management of pleural diseases. J. Deslauriers. The C.V. Mosby Co. Editors Norman C. Delaure and Henry Eschapasse. 6:197-204.
253. 1990 Susceptibility of Haemophilus influenzae to antimicrobial agents in Canada Can Med Ass J. 895-901.
254. 1990 Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery Antimicrobial Agents Chemotherapy. 34:1699-1702.
255. 1990 Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats. Antimicrobial Agents Chemotherapy. 34:576-580.
256. 1990 Endotoxin increases the nephrotoxic potential of gentamicin and the combination vancomycin-gentamicin Journal of Infectious Diseases. 161:721-727
257. 1990 Effect of S. faecalis pyelonephritis on the intracortical accumulation kinetic of gentamicin in rats Can Journal of Infectious Diseases. 1:117-120.
258. 1990 Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats. Antimicrobial Agents Chemotherapy. 34:889-895.
259. 1989 Influence of indomethacin on the intrarenal uptake of gentamicin in endotoxemic rats. Antimicrobial Agents Chemotherapy. 33:1342-1345.
260. 1989 In Clinical Management. AIDS summary. A practical synopsis of the V international conference. Editor Philadelphia Sciences Group. 172-226
261. 1989 Isolation and biochemical characterization of Haemophilus influenzae species isolated simultaneously from the oropharyngeal and anogenital areas. Journal of Clinical Microbiology. 27:1486-1489
262. 1989 Effect of age on the intracortical accumulation kinetics of gentamicin in rats. Antimicrobial Agents Chemotherapy. 33: 2006-2008.
263. 1989 Intrarenal distribution of vancomycin in endotoxemic rats. Antimicrobial Agents Chemotherapy. 33(9):1575-1579.
264. 1989 False resistance of Streptococcus faecalis to enoxacin by disc diffusion susceptibility tests. Journal of Antimicrobial Chemotherapy 23(1):158-160.
265. 1989 Current concepts in the treatment of pyelonephritis Internal Medicine. 10:65-84.
266. 1989 Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. Journal of Infectious Diseases 160(3):433-441.
267. 1989 Randomized comparison of norfloxacin and trimethoprim-sulfamethoxazole for the treatment of uncomplicated acute infections of the lower and upper urinary tract in women Reviews of Infectious diseases. 11(Suppl. 5) S1350.
268. 1988 Pharmacokinetic advantages of erythromycin Antimicrobial Agents Chemotherapy. 32(4):561-565
269. 1988 Pharmacokinetics of carumonam after single and multiple 1- and 2-g Dosage regimens Antimicrobial Agents Chemotherapy. 32(3):354-357.
270. 1988 Renal pharmacokinetic changes of gentamicin during enteroccocal pyelonephritis Antimicrobial Agents Chemotherapy. 32(5):736-739.
271. 1988 Ciprofloxacin in patients with cystic fibrosis: pharmacokinetics and pharmacodynamics. Review of Infectious Diseases 10(Suppl. 1):s223.
272. 1988 Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections Antimicrobial Agents Chemotherapy. 32:1231-1236.
273. 1988 In Pharmacologie: des concepts fondamentaux aux applications therapeutiques. Aminosides et polypeptides. Editor Michel Schorderet. Editions Slatkine, Genève. 691-699.
274. 1988 Urinary tract infections. In Textbook of Therapeutic Medicine A.H. Samly ed. Lea and Febiger.
275. 1988 Characterization of a plasmid isolated from Branhamella catarrhalis and detection of plasmid sequences within the genome of a B catarrhalis strain. Plasmid 20:158-162.
276. 1987 Pharmacokinetics of erythromycin's esters after single and multiple doses. Clin Pharmacol Ther 41:239.
277. 1987 Endophalmitis associated with Haemophilus influenzae type B meningitis in infant rats. Pediatric Infectious Diseases J. 6(8):770.
278. 1987 Metastatic Pseudomonas endophthalmitis following bronchoscopy Can J Ophthalmol 22(7):378-80.
279. 1987 Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against Antimicrobial Agents Chemotherapy. 20:663-669.
280. 1987 High-performance liquid chromatographic assay of erythromycin and its esters using electrochemical detection. J Chromat. 419:205-212.
281. 1987 Influence of hydrocortisone succinate on intrarenal accumulation of gentamicin in endotoxemic rats Antimicrobial Agents Chemotherapy. 31(11):1816-1821.
282. 1987 Autoradiographic study of tobramycin uptake by proximal and distal tubules of normal and pyelonephritic rats Antimicrobial Agents Chemotherapy. 31(9):1359-1364.
283. 1987 Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial. Pediatr Infect Dis J, 6:654-660.
284. 1987 Antibiotherapie parenterale a domicile: experience au Centre hospitalier de l'Universite Laval. L'Union Medicale du Canada 116:190-3.
285. 1987 Isolation and molecular characterisation of B-lactamase producing Haemophilus parainfluenzae from the genital tract. Antimicrobial Agents Chemotherapy. 31(6):966-968.
286. 1987 Influence of growth medium and added supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics. J Clin Microb 25(4):650-655.
287. 1986 Pharmacokinetics of ciprofloxacin in elderly volunteers Pharmacotherapy. 6(2):87-91.
288. 1986 Tissue penetration of ciprofloxacin after single and multiple doses Antimicrobial Agents Chemotherapy. 29(3):501-505.
289. 1986 Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-Hydroxybenzoylglycine, a drug-binding inhibitor in uremia. Ther Drug Monitoring 8:483-489.
290. 1986 Pharmacocinetique des aminosides chez les patients atteints de fibrose kystique Can J Hosp Pharm 39(5):130-134.
291. 1986 Influence of three modes of administration on the penetration of latamoxef into interstitial fluid and fibrin clots and its in vivo activity against Haemophilus influenzae J Antimicrobial Chemotherapy. 17:775-784
292. 1986 In-vitro uptake of gentamicin and tobramycin by rat renal tubules in the presence or absence of Escherichia coli endotoxin J Antimicrobial Chemotherapy. 18:375-380.
293. 1986 Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin and cephalothin. Antimicrobial Agents Chemotherapy. 29(1):7-12.
294. 1986 Comparative study of serum bactericidal activity of cefotaxime alone or in combination with tobramycin Antimicrobial Agents Chemotherapy. 29(2):379-381
295. 1986 Penetration of cefixime into fibrin clots and In Vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. Antimicrobial Agents Chemotherapy. 30(6):913-6
296. 1986 Tissue fluid pharmacokinetic models in humans and animals Dans : Experimental Models in Antimicrobial Chemotherapy. 71-107. Academic Press Inc. (London).
297. 1986 In rate-controlled delivery of antibiotics, rate-controlled drug administration and action. H. Struyker-Boudier CRC Press Inc., Boca-Raton, F.L. 222-245.
298. 1986 Benefit from high levels of gentamicin in the treatment of E. coli pyelonephritis Kidney International. 30:481-487.
299. 1986 Autoradiography of tobramycin uptake by the proximal and distal tubules of normal and endotoxin-treated rats. Antimicrobial Agents Chemotherapy. 29(6):1005-1009.
300. 1986 Determination of ciprofloxacin in biological samples by reversed-phase high performance liquid chromatography Therapeutic Drug Monitoring 8:340-345.
301. 1985 Therapeutic potential of high renal levels of aminoglycosides in pyelonephritis Antimicrobial Agents Chemotherapy. 15:4-8.
302. 1985 In essentials of infectious diseases. Urinary tract infections Mandell et E.D. Ralph. Blackwell Scientific Publications, Boston, MA. 253-265.
303. 1985 Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery Antimicrobial Agents Chemotherapy. 27:928-932.
304. 1985 False resistance of Streptococcus faecalis and Pseudomonas maltophillia to norfloxacin by disc diffusion susceptibility testing Antimicrobial Agents Chemotherapy. 16(1):132-133.
305. 1985 Serum bactericidal activity of ceftazidime increased by netilmicin. Drug Intelligence Clinical Pharmacy. 19:932-936
306. 1985 Pharmacokinetics of ceftazidime in elderly volunteers. Antimicrobial Agents Chemotherapy. 28:713-715
307. 1985 In vitro activity of norfloxacin against 4003 isolates: a multicentre study in Canada Current Therapeutic Research 38(1):169-172.
308. 1985 Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on In Vivo efficacy against Haemophilus influenzae Antimicrobial Agents Chemotherapy. 28(3):404-412.
309. 1985 Norfloxacin penetration into human renal and prostatic tissues Antimicrob Agents Chemother. August, 28(2):349-350.
310. 1985 Antibiotics Antimicrobial Agents Chemotherapy. August, 28(2):320-325
311. 1985 Increased nephrotoxicity of gentamicin in pyelonephritic rats. Kidney International. 28:106-113.
312. 1985 Difference in blister fluid penetration after single and multiple soses of ceftriaxone Antimicrobial Agents Chemotherapy. 28(1):123-127.
313. 1984 A guide to immunization for Canadians 2nd edition, 1984. Published by the authority of the Honorable Jake Ep
314. 1984 In : Infections. Abdominal infections. Recognition, understanding, treatment. J.C. Pechère, Lea et Febiger. 19:249-267.
315. 1983 Clinical evaluation of cefoxitin in the treatment of intra-abdominal and pelvic infections: a multicenter study in Canada Curr. Ther. Res. 33:528-538.
316. 1983 Three to eight weeks of therapy with netilmicin: toxicity in normal and diabetic patients. Antimicrobial Agents Chemotherapy. 12:245-248.
317. 1983 Cefoperazone: a comparative in vitro canadian study of 1743 pathogens, Canadian infectious disease study group Can. J. Pub. Health 74:409-413.
318. 1983 Randomized controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin Lancet 1:1123-1126
319. 1983 In : Infections. Suppurations abdominales In : Infections. Suppurations abdominales
320. 1982 Long-term therapy with netilmicin Current Chemotherapy and Immunotherapy II: 883-885.
321. 1982 Increased nephrotoxicity of gentamicin in the presence of infection Current Chemotherapy and Immunotherapy II: 811-813
322. 1982 Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin, and cephalothin against 118 strains of H. influenzae including tolerant microorganisms J Antimocrob. Chemother. 10:397-402
323. 1982 Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis. J. Infect. Dis. 146:436-439.
324. 1982 Significance of intrarenal concentrations of gentamicin on the outcome of experimental pyelonephritis in rats J. Infect. Dis. 146:91-96.
325. 1982 Netilmicin in the treatment of acute pyelonephritis: a multicentric study Current Chemotherapy and Immunotherapy. II: 864-865.
326. 1982 Therapy of serious infections in hospitalized patients. Current Chemotherapy and Immunotherapy. I:606-608.
327. 1981 Limited in vitro activity of cefamandole against 100 Beta-lactamase and non Beta-lactamase producer strains of Haemophilus influenzae: a comparison of moxalactam, chloramphenicol and ampicillin Antimicrobial Agents Chemotherapy. 19:101-105.
328. 1981 Intrarenal concentrations of ampicillin in acute pyelonephritis Antimicrobial Agents Chemotherapy. 19:761-765.
329. 1981 Hematurie inusitee par auto-amputation d'un polype fibreux pseudo-parasitaire de l uretere CMAJ. 124:170-172.
330. 1981 Continuous or intermittent administration of antimicrobial agents: tissue penetration and in vivo efficacy Review Infectious Diseases. 3:84-97.
331. 1980 Efficacy and penetration of several antibiotics in fibrin clots infected with ampicillin resistant Haemophilus influenzae. Current Chemotherapy: II, 1027-1029.
332. 1980 Intrarenal distribution of trimethoprim and sulfamethoxazole. Antimicrobial Agents Chemotherapy. 17:383-388.
333. 1980 Comparative in vivo efficiency of cefamandole and cefoxitin against J. Infect. Dis. Suppl. 26:60-65
334. 1979 The influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary and papillary distribution Antimicrobial Agents Chemotherapy. 15:635-641.
335. 1979 In : Infections, Suppurations abdominales J.C. Pechere, Edisem, Quebec, Maloine, S.A., Paris, 24:265-279.
336. 1978 Influence of constant infusion vs bolus injections of antibiotics on in vivo synergy. Infection. Suppl. 1(38-46).
337. 1978 Intrarenal concentration of netilmicin and gentamicin. Current Chemotherapy: 953-955.
338. 1977 La gonococcie systemique, cette meconnue Union Medicale Canadienne. 106:316-323.
339. 1977 Techniques d'isolement en milieu hospitalier. Union Medicale Canadienne. 106:999-1005
340. 1977 Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots. Antimicrobial Agents Chemotherapy. 12:682-687.
341. 1977 de diphterie survenue sur la Cote Nord du St-Laurent a l'automne de 1974. Can Med Ass. 116:1279-1283.
342. 1976 Bactericidal activity and pharmacology of flucloxacillin Am J Med Sci. 271:13-20.
343. 1976 Comparative pharmacokinetics of 13 antibiotics in dogs with special reference to concentrations in liver, kidney, bile and urine Infection 4:582-90.
344. 1976 Effect of pH on the phlebitogenic potential of Keflin. Antimicrobial Agents Chemotherapy. 9:646-648.
345. 1975 Effect of diuretics on urinary excretion of cephalothin in man. Antimicrobial Agents Chemotherapy. 7:168-171.
346. 1975 Colite ulcereuse et thrombose veineuse cerebrale Union Medicale 104:414-417
347. 1975 Extraction of antibiotics from circulation by liver and kidney and the effect of probenecid J. Infect. Dis. 131: S, 86-97.
348. 1975 Renal tubular transport of penicillin G and carbenicillin in the rat. J. Infect. Dis. 132:374-383
349. 1974 An in vitro and pharmacological comparison of amoxicillin and ampicillin. Am J Med Sci. 267:40-48.
350. 1973 Penetration of antibiotics into fibrin loci in vivo. III. Intermittent versus continuous infusion and the effect of probenecid J. Infect. Dis. 129:73-78.
351. 1973 Bactericidal activity and pharmacology of cefazolin. Antimicrobial Agents Chemotherapy. 4:396-401.
352. 1973 Selective filtration of antibiotics through collodion membranes. Antimicrobial Agents Chemotherapy. 4:337-342
353. 1972 Cross-resistance of pseudomonas to gentamicin and tobramycin. Antimicrobial Agents Chemotherapy. 1:280-281
354. 1970 Application de la diete de giordonna-giovannetti chez 23 patients souffrant d'insuffisance renale avancee Laval Medical. 41:340-344.
355. 1967 Immunite des maladies a virus Laennec Medical 18, 4:13-17

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.